0001609351-19-000004.txt : 20190104
0001609351-19-000004.hdr.sgml : 20190104
20190104160423
ACCESSION NUMBER: 0001609351-19-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190103
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PEREZ ROBERT J
CENTRAL INDEX KEY: 0001263230
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36819
FILM NUMBER: 19510001
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER ST.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spark Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609351
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462654405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 888-772-7560
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
wf-form4_154663584200619.xml
FORM 4
X0306
4
2019-01-03
0
0001609351
Spark Therapeutics, Inc.
ONCE
0001263230
PEREZ ROBERT J
C/O SPARK THERAPEUTICS, INC.
3737 MARKET STREET, SUITE 1300
PHILADELPHIA
PA
19104
1
0
0
0
Common Stock
2019-01-03
4
M
0
1000
A
1000
D
Restricted Stock Units
2019-01-03
4
M
0
1000
0
D
Common Stock
1000.0
2000
D
Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
On January 3, 2018, the reporting person was granted 3,000 restricted stock units that vest in three equal annual installments beginning January 3, 2019. Vested shares will be delivered to the reporting person annually on the vesting date.
/s/ Joseph W. La Barge, attorney-in-fact for Robert J. Perez
2019-01-04